The Cost of Doing Business

Hello trader, Ask any trader worth their salt and they'll tell you straight up—the name of the game is EDGE—find yours and exploit it.  However, elite traders move in silence.  You see, the market is extremely efficient.  A highly profitable strategy can work today but cease to exist later down the road.  That's why I'm always wary of technical analysis indicators or any other so-called "edge" that relies on past data.  Why do you think most economists get it wrong? It's because they spot the trend after the fact, and by that time, the easy money has already been made. But what if you could get into trades before the news hit?  And instead of chasing that fast-moving stock… you're peeling off profitable positions to the JOHNNY-COME-LATELY crowd. In a few minutes, I'll be hosting a training class that will teach you how this all works. You see, instead of waiting for news to hit, or the chart "to set up"-- I'm able to get way ahead on these trades by simply following the money. It's no secret that the world's top traders use options to leverage their ideas and manage risk. However, most retail traders fail to realize that the world's richest and most powerful institutions are LEAVING FOOTPRINTS.  Now, in order to track these footprints, I'm shelling out thousands of dollars each year in technology and infrastructure fees—as you'll learn in this training (that will begin shortly). Imagine jumping into some cheap, ready to expire options, only to have a news catalyst hit, and watch those options move from Dead on Arrival (D.O.A)  to Deep-In-The-Money and extremely profitable.  Don't believe me? Register for my training to see it for yourself. I'll teach how to trade newsworthy companies before they become newsworthy. And when headlines like this hit: Your friends will think you're Harry Houdini, pulling magic tricks, 'cause you were in the position days in advance.  Join my training to see how it all works. You'll learn to cut out the noise, and listen to the one indicator that matters the most—where the institutions are putting their actual money to work.  After you attend the training, you'll learn: How to uncover a gold mine of "actionable" information that drastically increases your chances of finding profitable trades A step-by-step process I use to find the correct options contract and strike price to trade (Hint: most traders get this wrong, despite no guessing required) How to piggyback off the most informed traders on the Street. And potentially profit alongside them How to keep the idea flow running—even when it appears like there is nothing to trade And a whole lot more.  This all starts shortly… see you there! Kyle Dennis RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 Click Here to stop receiving emails from kyle@biotechbreakouts.com Unsubscribe from all RagingBull emails Neither Kyle Dennis nor RagingBull.com, LLC (publisher of BiotechBreakouts) is registered as an investment adviser nor a broker/dealer with either the U. S. Securities & Exchange Commission or any state securities regulatory authority. Users of this website are advised that all information presented on this website is solely for informational purposes, is not intended to be used as a personalized investment recommendation, and is not attuned to any specific portfolio or to any user's particular investment needs or objectives. The owners, employees and writers of RagingBull.com may engage in securities trading that is discussed or viewed on this website, but all such individuals are buying and selling such securities for their own account. These individuals do not engage in any trades with customers. The buying and selling of securities by these individuals is not part of a regular business of buying and selling securities. Past performance is NOT indicative of future results. Furthermore, such information is not to be construed as an offer to sell or the solicitation of an offer to buy, nor is it to be construed as a recommendation to buy, hold or sell (short or otherwise) any security. All users of this website must determine for themselves what specific investments to make or not make and are urged to consult with their own independent financial advisors with respect to any investment decision. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. All opinions, analyses and information included on this website are based on sources believed to be reliable and written in good faith, but should be independently verified, and no representation or warranty of any kind, express or implied, is made, including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. In addition, we undertake no responsibility to notify such opinions, analyses or information or to keep such opinions, analyses or information current. Also be aware that owners, employees and writers of and for RagingBull.com, LLC may have long or short positions in securities that may be discussed on this website or newsletter, but all such positions are held for such representative's own account. Past results are not indicative of future profits. This table is accurate, though not every trade is represented. Profits and losses reported are actual figures from the portfolios Kyle Dennis manages on behalf of RagingBull.com, LLC. If you have a current active subscription with Biotech Breakouts you will need to contact us here if you want to cancel your subscription. Opting out of emails does not remove you from your service at BiotechBreakouts.com.